MIRA
INFORM REPORT
|
Report Date : |
15.09.2011 |
IDENTIFICATION DETAILS
|
Name : |
MOIRAE GENERICS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
C – 68, Neeti Bagh, (2nd Floor), New Delhi – 110049 |
|
|
|
|
Country : |
|
|
|
|
|
Date of
Incorporation : |
04.02.2010 |
|
|
|
|
Com. Reg. No.: |
198694 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.1.623
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U51909DL2010FTC198694 |
|
|
|
|
Legal Form : |
Private Limited Liability Company. |
|
|
|
|
Line of Business
: |
Trader and Distributors of Pharmaceuticals Medicines. |
|
|
|
|
No. of Employees
: |
5 (Approximately) (Only for Registration Purpose Note employees Working here) |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
Status : |
|
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a new company establishing itself gradually. The company has
achieved sizable turnover in its very first year of operation. Trade
relations are reported as fair. Business is active. Payment terms are
unknown. The company can be considered for business dealings with some caution.
|
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
|
|
|
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Jacob Fiedler |
|
Designation : |
Director |
|
Contact No.: |
91-9769664422 |
|
Date : |
13.09.2011 |
LOCATIONS
|
Registered Office : |
C – 68, Neeti Bagh, 2nd Floor, New Delhi – 110049, India |
|
Mobile No.: |
91-9769664422 (Mr. Jacob Fiedler) 91-9920065770 (Mr. Martin Frandsen) |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate Office : |
B-710, Sagar Tech Plaza, Saki Naka Junction Andheri (East), Mumbai – 400072,
Maharashtra, India |
|
Tel. No.: |
91-22-40155008/ 40155002 |
|
Fax No.: |
91-22-42911024 |
|
Area : |
1,200 |
|
Location : |
Leased |
DIRECTORS
|
Name : |
Mr. Jacob Sporon Fiedler |
||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||
|
Address : |
Livornovej 9, Copernhagen S 2300 |
||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
22.08.1981 |
||||||||||||||||||||||||||||||||
|
DIN No.: |
01660842 |
||||||||||||||||||||||||||||||||
|
Other Directorship : |
|
||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||
|
Name : |
Mr. Martin Hejgaard Frandsen |
||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||
|
Address : |
No.501, Block A, Lake Lucerne, Lake Homes, Phase 3, Powai, Mumbai –
400069, Maharashtra, India |
||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
27.06.1975 |
||||||||||||||||||||||||||||||||
|
Date of Appointment : |
29.07.2011 |
||||||||||||||||||||||||||||||||
|
Email : |
|||||||||||||||||||||||||||||||||
|
DIN N.: |
03529339 |
||||||||||||||||||||||||||||||||
|
Other Directorship : |
|
||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
(AS ON 16.06.2010)
|
Names of Allottees |
|
No. of Shares
Allotted |
|
|
|
|
|
Moirae Capital Ventures Limited, Victoria |
|
9999 |
|
Jacob Sporon Fiedler |
|
1 |
|
|
|
|
|
Total |
|
10000 |
(AS ON 29.07.2011)
|
Names of Allottees |
|
No. of Shares
Allotted |
|
|
|
|
|
Moirae Capital Ventures Limited, Victoria |
|
62300 |
|
|
|
|
|
Total |
|
62300 |
BUSINESS DETAILS
|
Line of Business : |
Trader and Distributors of Pharmaceuticals Medicines. |
|
|
|
|
Agencies Held : |
Alpha – Pharma |
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceutical Medicines |
|
Countries : |
· Denmark · UK · France · Germany · USA |
|
|
|
|
Terms : |
|
|
Selling : |
L/C, Cash and Credit |
|
|
|
|
Purchasing : |
Cash and Credit |
GENERAL INFORMATION
|
Customers : |
Wholesalers, Retailers and Pharma Companies. |
|
|
|
|
No. of Employees : |
5 (Approximately) (Only for Registration Purpose Note employees Working here) |
|
|
|
|
Bankers : |
· Standard Chartered Bank Goregaon Branch , Mumbai, Maharashtra, India |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Borkar and Shonoy Chartered Accountant |
|
|
|
|
Parent Company : |
· Moirae Capital Ventures |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
250000 |
Equity Share |
Rs.10/- each |
Rs.2.500 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
162300 |
Equity Share |
Rs.10/- each |
Rs.1.623
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
NEW COMPANY
|
Particulars |
|
|
31.03.2011 |
|
Sales Turnover (Approximately) |
|
|
240.000 |
|
|
|
|
|
The above information has been parted by Mr. Jacob Fiedler.
LOCAL AGENCY FURTHER INFORMATION
TRADE REFERENCE:
· Alpha Pharma
· June Medicare – Denmark
WEBSITE DETAILS:
COMPANY INFORMATION
Subject has been incorporated in January 2010 with the purpose of offering a simplified and automated service for drop-shipping and sourcing requirements of online pharmacies.
They have a clear focus on the service aspect of the online pharmacy business and not just the product pricing. The understanding of the service requirements helps their clients retain their customs by enabling their clients to monitor the dispatch of consignments and content of each parcel on a daily or real-time basis.
The integrated supply chain system offers a simple, and yet functional, solution to place, manager and monitor orders from submission to dispatch and delivery. The system further evaporates the communication gap that daily emails causes both in terms of human errors and time-zone issues.
LEGAL
INFORMATION
As a
company registered with the Food and Drug Administration they are legally
permitted and licensed to dispatch all medicines (with the exception of
narcotic drugs and psychotropic substances) to all countries, however, there
are still countries that prohibit the import of certain generic medicines
despite the major savings that its citizens could gain on their medications.
These import restrictions are difficult for them to verify and confirm why they
leave it up to their clients to ensure that it the products that are ordered
does not violate any law in the destination countries except for the products
which they are fully aware cannot be legally imported with major documentation,
e.g. anabolic steroids to the United States.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject : None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.47.81 |
|
|
1 |
Rs.75.16 |
|
Euro |
1 |
Rs.65.11 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.